Search results for: "johnson johnson" (218 records) Phylogica enters peptide agreement with Janssen Biotech To identify cell-penetrating Phylomer peptides Molecular Partners signs DARPin agreement with Janssen Biotech Swiss firm could receive payments worth US$800m You need to be a subscriber to read this article. Click here to find out more. Ingredients Faster optimisation of biocatalysts Developing an enzymatic process for synthesising a chiral compound is generally a multi-step procedure. The characteristics of the enzyme must be fine-tuned to meet the process... US FDA approves Xarelto for AF patients To cut the risk of stroke in this patient group LIVE FROM CPhI 2011: Johnson Matthey opens catalyst plant in Shanghai Includes production facility and research centre Research & Development Antidiabetic agent – canagliflozin The need for effective drug treatments for Type II diabetes has never been more important, particularly in the light of the problems experienced by some of the drugs that have... Innovation Award finalists revealed CPhI Innovation Award winners will be selected from drug delivery, packaging and process developments EU approves Zytiga for metastatic castration-resistant prostate cancer First once-daily, oral treatment inhibits androgen production at all sources Johnson Matthey reports 11% profit All parts of the specialist chemicals group see sales growth Approved nces find their niche Blockbusters may be in short supply but the latest new chemical entities to receive the EMA’s go-ahead promise to improve delivery, simplify compliance and extend patient... FDA takes action against McNeil-PPC Charged with manufacturing and distributing otc drugs in violation of federal law Pepscan Therapeutics signs agreement with Crucell Partners aim to develop of novel vaccines to combat infectious diseases Johnson Matthey integrates X-Zyme biocatalyst products Biocatalytic technology enables Johnson Matthey to offer highly efficient, sustainable solutions Medivir signs dengue virus deal with Janssen Strengthens presence in infectious diseases Crucell hit by charges relating to Quinvaxem European Commission approves Johnson & Johnson takeover of Dutch company Research & Development Drug licensing deals in 2010 Big pharma companies have been busy filling the yawning gaps in their product pipelines by licensing drugs developed by smaller biotechnology firms. Dr Sarah Houlton outlines a... Previous1…891011 (current)121314Next
